Jon Irvin serves as Executive at Mirna Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jon Irvin has executed 5 insider transactions totaling $1.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 1, 2016 involved selling 280 shares valued at $400.
Jon Irvin currently holds 7,625 shares of Mirna Therapeutics, Inc. (MIRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jon Irvin has been a net seller of MIRN stock. They have purchased $0 and sold $1.7K worth of shares.
Jon Irvin's most recent insider trade was on Dec 1, 2016, when they sold 280 shares at $1.43 per share.
Get notified when new Form 4 filings are submitted
| $1.45 |
| Discretionary |
| Nov 1, 2016 | MIRN | $358 | Sale | 280 | $1.28 | Discretionary |
| Oct 11, 2016 | MRIN | $275 | Sale | 150 | $1.83 | Discretionary |
| Oct 3, 2016 | MIRN | $483 | Sale | 250 | $1.93 | Discretionary |